top of page

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

ULY CLINIC

20 Februari 2026, 04:36:31

Role of Nutrition in COVID-19

Role of Nutrition in COVID-19
Role of Nutrition in COVID-19
Role of Nutrition in COVID-19
Role of Nutrition in COVID-19

Adequate nutrition is essential for optimal cellular function, particularly immune cells. During infection with COVID-19, the body enters a hyper-metabolic inflammatory state characterized by increased catabolism, oxidative stress, cytokine activation and accelerated protein breakdown. When dietary intake is insufficient, the body mobilizes endogenous stores (muscle protein, glycogen, fat, and micronutrient reserves), leading to:

  • Lean body mass loss

  • Immune dysfunction

  • Delayed recovery

  • Increased complications and mortality

Therefore, nutrition therapy is considered a core therapeutic intervention rather than supportive care alone.


TARGET POPULATION

This guidance applies to:

  • Infants and young children

  • Adolescents

  • Adults

  • Elderly

  • Pregnant and lactating mothers

  • Patients with chronic illnesses:

    • Hypertension

    • Diabetes mellitus

    • Cancer

    • Cardiovascular disease

    • Renal disease


A. PATHOPHYSIOLOGICAL EFFECTS OF COVID-19 ON NUTRITION


1. Hypermetabolism and Catabolism

Fever increases basal metabolic rate by ~10–13% per 1°C rise in temperature.

Consequences:

  • Rapid glycogen depletion

  • Lipolysis

  • Skeletal muscle proteolysis

  • Negative nitrogen balance


2. Micronutrient Depletion

Inflammation and oxidative stress cause increased consumption and urinary loss of:

Micronutrient

Function

Zinc

Antiviral immunity

Iron

Oxygen transport

Folate

Cell division

Vitamin A

Mucosal barrier integrity

Vitamin C

Antioxidant & leukocyte function

Vitamin E

Cellular protection


3. Gastrointestinal Dysfunction

Cytokine effects impair digestion:

  • Reduced gastric emptying

  • Malabsorption

  • Nausea/vomiting

  • Diarrhea

Result: Reduced nutrient availability despite intake.


4. Fluid and Electrolyte Imbalance

Due to:

  • Fever

  • Sweating

  • Tachypnea

  • Diarrhea


Leads to:

  • Dehydration

  • Hypokalemia

  • Metabolic disturbances


5. Anorexia and Sensory Changes

Common symptoms:

  • Loss of smell (anosmia)

  • Loss of taste (ageusia)

  • Early satiety

  • Fatigue

→ Reduced caloric intake


B. GENERAL NUTRITIONAL RECOMMENDATIONS


Balanced Diet Composition

Patients should consume foods from all major food groups daily:


1. Energy Sources

Cereals, roots and tubers

  • Rice

  • Maize

  • Wheat

  • Cassava

  • Sweet potatoes

  • Yams

  • Plantains

Purpose: Prevent protein breakdown for energy


2. Protein Sources

Animal + plant proteins


Animal:

  • Meat

  • Fish

  • Eggs

  • Milk

  • Yogurt

  • Sardines


Plant:

  • Beans

  • Lentils

  • Cowpeas

  • Groundnuts

  • Sesame

  • Sunflower seeds


Purpose:

  • Antibody synthesis

  • Muscle preservation

  • Tissue repair


3. Vegetables

Examples:

  • Amaranth

  • Pumpkin leaves

  • Spinach

  • Okra

  • Carrots

  • Eggplant

  • Tomatoes


Provide:

  • Fiber

  • Folate

  • Antioxidants


4. Fruits

Vitamin-rich fruits:

Vitamin A

Vitamin C

Mango

Guava

Papaya

Citrus

Pumpkin

Baobab

Yellow fruits

Tamarind


5. Fats and Oils

  • Vegetable oils

  • Coconut oil

  • Butter

  • Nuts

Purpose:

  • High-density calories

  • Anti-inflammatory fatty acids


C. SYMPTOM-SPECIFIC DIETARY MANAGEMENT


i. Fever

Goals: Hydration + energy preservation

  • ≥8 glasses water/day

  • Oral rehydration fluids

  • High-protein small meals

  • Fruit juices


ii. Cough / Cold / Flu

  • Vitamin C rich fruits

  • Warm fluids

  • Ginger, garlic, turmeric

  • Green vegetables


iii. Sore Throat

  • Soft diet (porridge, mashed foods)

  • Warm foods

  • Avoid spicy & acidic foods

  • Saline gargles


iv. Nausea and Vomiting

  • Small frequent meals

  • Dry foods (crackers)

  • Avoid greasy foods

  • Do not lie immediately after meals


v. Loss of Taste or Smell

  • Flavor enhancers (herbs, spices)

  • Textured foods

  • Frequent meals


vi. Prevention of Anemia

Increase intake of:

  • Iron

  • Vitamin B12

  • Folate

Enhance absorption with vitamin CAvoid tea/coffee near meals.


D. FLUID MANAGEMENT


Fluid Overload (e.g., heart failure, renal disease)

  • Sodium restriction

  • Controlled fluid intake

  • Adjust potassium depending on diuretics


E. CO-MORBIDITY-SPECIFIC NUTRITION

Nutrition must be individualized for:

Condition

Key Consideration

Diabetes

Glycemic control

Renal disease

Protein & electrolyte restriction

Cardiac disease

Sodium control

Cancer

High protein high calorie


F. NUTRITION IN CRITICALLY ILL PATIENTS

Critically ill patients frequently develop severe catabolism and may progress to Acute Respiratory Distress Syndrome requiring ICU admission.


1. Initial Assessment

Evaluate:

  • Recent weight loss

  • Muscle mass

  • Functional decline

  • Pre-ICU intake


2. Feeding Route Priority

  1. Oral feeding (preferred)

  2. Enteral nutrition (within 48 hrs)

  3. Parenteral nutrition (3–7 days if needed)


3. Energy Targets

Early phase (Days 1–3):

  • ≤70% energy needs

Stabilization (Days 3–7):

  • 80–100% energy requirements

Purpose: Prevent overfeeding and refeeding syndrome


4. Protein Targets

High protein required to prevent muscle wasting.


5. Micronutrients

Provide daily:

  • Trace elements

  • Vitamins

Avoid high-dose antioxidant monotherapy unless deficiency proven.


6. When to Delay Enteral Feeding

Contraindications:

  • Uncontrolled shock

  • Severe hypoxemia

  • Severe acidosis

  • GI bleeding

  • High gastric residual (>500 ml)

  • Intestinal fistula


7. Special Considerations

  • Early enteral feeding improves survival

  • Avoid overfeeding

  • Monitor tolerance daily


KEY CLINICAL PRINCIPLE

Nutrition therapy is a disease-modifying treatment in COVID-19 — not merely supportive care.Early, adequate, and individualized nutrition significantly reduces complications, ICU stay, and mortality.


References

  1. Ministry of Health, Community Development, Gender, Elderly and Children (United Republic of Tanzania). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. March 2021.

  2. World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected. WHO; 2020.

  3. World Health Organization. Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. WHO Interim Guidance; 2020.

  4. World Health Organization. Coronavirus disease (COVID-19) Situation Report – 46. WHO; 2020.

  5. Del Rio C, Malani PN. 2019 Novel Coronavirus—Important Information for Clinicians. JAMA. 2020;323(11):1039-1040.

  6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-1720.

  7. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of COVID-19 pneumonia in Wuhan, China. Lancet. 2020;395(10223):507-513.

  8. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China. Lancet. 2020;395:1054-1062.

  9. Zhao D, Yao F, Wang L, Zheng L, Gao Y, Ye J, et al. A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. Clin Infect Dis. 2020.

  10. Yoon SH, Lee KH, Kim JY, Lee YK, Ko H, Kim KH, et al. Chest Radiographic and CT Findings of COVID-19: Analysis of Nine Patients Treated in Korea. Korean J Radiol. 2020;21(4):494-500.

  11. Peng QY, Wang XT, Zhang LN. Findings of lung ultrasonography of COVID-19 pneumonia. Intensive Care Med. 2020.

  12. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 compared with SARS-CoV-1. N Engl J Med. 2020;382:1564-1567.

  13. Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign Guidelines on the Management of Critically Ill Adults with COVID-19. Crit Care Med. 2020.

  14. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.

  15. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307(23):2526-2533.

  16. Australian and New Zealand Intensive Care Society (ANZICS). COVID-19 Guidelines. Melbourne; 2020.

  17. World Confederation for Physical Therapy. Physiotherapy management for COVID-19 (Version 1.0). 2020.

  18. Queensland Health Clinical Excellence Division. COVID-19 Action Plan: Statewide General Medicine Clinical Network. 2020.


Imeandikwa:

24 Machi 2021, 19:36:10

bottom of page